Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Landecho, M.F. (Manuel F.) | - |
dc.creator | Tuero, C. (Carlota) | - |
dc.creator | Valenti, V. (Víctor) | - |
dc.creator | Bilbao, I. (Idoia) | - |
dc.creator | Higuera, M. (Magdalena) de la | - |
dc.creator | Frühbeck, G. (Gema) | - |
dc.date.accessioned | 2021-11-11T09:37:21Z | - |
dc.date.available | 2021-11-11T09:37:21Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Landecho, M.F. (Manuel F.); Tuero, C. (Carlota); Valenti, V. (Víctor); et al. "Relevance of leptin and other adipokines in obesity-associated cardiovascular risk". Nutrients. 11 (11), 2019, 2664 | es_ES |
dc.identifier.issn | 2072-6643 | - |
dc.identifier.uri | https://hdl.handle.net/10171/62537 | - |
dc.description.abstract | Obesity, which is a worldwide epidemic, confers increased risk for multiple serious conditions including type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular diseases. Adipose tissue is considered one of the largest endocrine organs in the body as well as an active tissue for cellular reactions and metabolic homeostasis rather than an inert tissue only for energy storage. The functional pleiotropism of adipose tissue relies on its ability to synthesize and release a large number of hormones, cytokines, extracellular matrix proteins, and growth and vasoactive factors, which are collectively called adipokines known to influence a variety of physiological and pathophysiological processes. In the obese state, excessive visceral fat accumulation causes adipose tissue dysfunctionality that strongly contributes to the onset of obesity-related comorbidities. The mechanisms underlying adipose tissue dysfunction include adipocyte hypertrophy and hyperplasia, increased inflammation, impaired extracellular matrix remodeling, and fibrosis together with an altered secretion of adipokines. This review describes the relevance of specific adipokines in the obesity-associated cardiovascular disease. | es_ES |
dc.description.sponsorship | GF reports grants from the Spanish Health Institute ISCIII, Subdirección General de Evaluación and Fondos FEDER PI16/01217, Plan Estatal I+D+I/2013–2016 and CIBEROBN, during the writing of this document. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI AG | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Obesity | es_ES |
dc.subject | Adipokines | es_ES |
dc.subject | Leptin | es_ES |
dc.subject | Resistin | es_ES |
dc.subject | Visfatin | es_ES |
dc.subject | Osteopontin | es_ES |
dc.subject | Adiponectin | es_ES |
dc.subject | Omentin-1 | es_ES |
dc.subject | Ghrelin | es_ES |
dc.subject | Obestatin | es_ES |
dc.title | Relevance of leptin and other adipokines in obesity-associated cardiovascular risk | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | es_ES |
dc.identifier.doi | 10.3390/nu11112664 | - |
dadun.citation.number | 11 | es_ES |
dadun.citation.publicationName | Nutrients | es_ES |
dadun.citation.startingPage | 2664 | es_ES |
dadun.citation.volume | 11 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.